Q3 2022 13F Holders as of 9/30/2022
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
28M
-
Number of holders
-
3
-
Total 13F shares, excl. options
-
882K
-
Shares change
-
-34.6M
-
Total reported value, excl. options
-
$5.68M
-
Value change
-
-$38.8M
-
Number of buys
-
1
-
Number of sells
-
-56
-
Price
-
$6.44
Significant Holders of Syros Pharmaceuticals, Inc. - Common Stock, $0.001 par value (SYRS) as of Q3 2022
59 filings reported holding SYRS - Syros Pharmaceuticals, Inc. - Common Stock, $0.001 par value as of Q3 2022.
Syros Pharmaceuticals, Inc. - Common Stock, $0.001 par value (SYRS) has 3 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 882K shares
of 28M outstanding shares and own 3.15% of the company stock.
Largest 10 shareholders include Samsara BioCapital, LLC (881K shares), Ten Capital Wealth Advisors, LLC (219 shares), IFP Advisors, Inc (50 shares), FEDERATED HERMES, INC. (0 shares), PRICE T ROWE ASSOCIATES INC /MD/ (0 shares), FMR LLC (0 shares), NORTHERN TRUST CORP (0 shares), Legal & General Group Plc (0 shares), STATE STREET CORP (0 shares), and CITIGROUP INC (0 shares).
This table shows the top 3 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.